» Articles » PMID: 38434094

Clinical Characteristics and Identification of Novel Variants in Three Unrelated Chinese Families with Vissers-Bodmer Syndrome

Overview
Journal Heliyon
Specialty Social Sciences
Date 2024 Mar 4
PMID 38434094
Authors
Affiliations
Soon will be listed here.
Abstract

Vissers-Bodmer Syndrome, an autosomal dominant disease, is a neurodevelopmental disorder characterized by global developmental delay, intellectual disability, hypotonia and autistic features with a highly variable phenotype. It is caused by variants in the CCR4-NOT transcription complex, subunit 1 gene (). However, the pathophysiologic mechanism of the Vissers-Bodmer Syndrome remains unclear. Notably, this syndrome has not been previously reported in the Chinese. In this study, we utilized whole exome sequencing to identify three novel variants in the gene, encompassing one frameshift variant and two missense variants, in three Chinese patients mainly presenting with developmental delay, intellectual disability and/or autism. Interestingly, three patients exhibited novel manifestations including spina bifida occulta, horse-shoe kidney and café-au-lait spot. The frameshift variant, p.Gly172Alafs*5, occurring , leading to a premature stop codon in the protein, was classified into pathogenic. Two missense variants c.3451A > G (p.Asn1151Asp) and c.557C > T (p.Ser186Phe) were predicted to be deleterious by multiple prediction algorithms with high conservation among a variety of species. Additionally, three-dimensional structure modeling and predicting indicated the substitution of the mutated amino acids would decrease the stability of CNOT1 protein. Given that is a relatively novel disease gene, we evaluated the gene-disease validity following ClinGen Standard Operating Procedure. The existing evidence substantiates a "Definitive" level of gene-disease relationship. The genetic findings provide a reliable basis for the genetic counseling of the family reproduction. Moreover, our results expand the genetic and phenotypic spectrum of -related Vissers-Bodmer Syndrome.

References
1.
Schafer I, Yamashita M, Schuller J, Schussler S, Reichelt P, Strauss M . Molecular Basis for poly(A) RNP Architecture and Recognition by the Pan2-Pan3 Deadenylase. Cell. 2019; 177(6):1619-1631.e21. PMC: 6547884. DOI: 10.1016/j.cell.2019.04.013. View

2.
Mathys H, Basquin J, Ozgur S, Czarnocki-Cieciura M, Bonneau F, Aartse A . Structural and biochemical insights to the role of the CCR4-NOT complex and DDX6 ATPase in microRNA repression. Mol Cell. 2014; 54(5):751-65. DOI: 10.1016/j.molcel.2014.03.036. View

3.
Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J . Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015; 17(5):405-24. PMC: 4544753. DOI: 10.1038/gim.2015.30. View

4.
Bawankar P, Loh B, Wohlbold L, Schmidt S, Izaurralde E . NOT10 and C2orf29/NOT11 form a conserved module of the CCR4-NOT complex that docks onto the NOT1 N-terminal domain. RNA Biol. 2013; 10(2):228-44. PMC: 3594282. DOI: 10.4161/rna.23018. View

5.
Strande N, Rooney Riggs E, Buchanan A, Ceyhan-Birsoy O, DiStefano M, Dwight S . Evaluating the Clinical Validity of Gene-Disease Associations: An Evidence-Based Framework Developed by the Clinical Genome Resource. Am J Hum Genet. 2017; 100(6):895-906. PMC: 5473734. DOI: 10.1016/j.ajhg.2017.04.015. View